We established both CLP- and LPS-induced sepsis models in mice and verified that SPION-MSCs significantly improved the symptoms of sepsis, such as increasing the survival rate of mice, reducing the levels of serum TNF-α, IL-6, ALT and AST, and relieving liver tissue damage. This evidence concerns the gene IL6 and Sepsis.